National Profile
Chlamydia
Figure 1. Chlamydia — Rates: Total and by sex: United States, 1989–2008
Figure 2. Chlamydia — Rates by region: United States, 1999–2008
Figure 3. Chlamydia — Rates by state: United States and outlying areas, 2008
Figure 4. Chlamydia — Rates by county: United States, 2008
Figure 5. Chlamydia — Age- and sex-specific rates: United States, 2008
Figure 6. Chlamydia — Rates by race/ethnicity: United States, 1999–2008
Figure 7. Chlamydia — Cases by reporting source and sex: United States, 1999–2008
Figure 8. Chlamydia — Prevalence by age group and race/ethnicity from a national survey, 1999–2002
Figure 9. Chlamydia — Median state-specific positivity among 15- to 24-year-old women tested in family planning clin ics: United States, 1997–2008
Figure 10. Chlamydia — Positivity among 15- to 24-year-old women tested in family planning clinics by state: United States and outlying areas, 2008
Figure 11. Chlamydia — Trends in positivity among 15- to 24-year-old women tested in family planning clinics by HHS region, 2004–2008
Figure 12. Chlamydia — Percent of nucleic acid amplification tests (NAATs) used in family planning clinics among 15- to 24-year-old women by HHS region, 2004–2008
View all Chlamydia figures as a color slideshow[PPT 481KB]
Gonorrhea
Figure 13. Gonorrhea — Rates: United States, 1941–2008
Figure 14. Gonorrhea — Rates: Total and by sex: United States, 1989–2008
Figure 15. Gonorrhea — Rates by region: United States, 1999–2008
Figure 16. Gonorrhea — Rates by state: United States and outlying areas, 2008
Figure 17. Gonorrhea — Rates by county: United States, 2008
Figure 18. Gonorrhea — Age- and sex-specific rates: United States, 2008
Figure 19. Gonorrhea — Age-specific rates among women 15 to 44 years of age: United States, 1999–2008
Figure 20. Gonorrhea — Age-specific rates among men 15 to 44 years of age: United States, 1999–2008
Figure 21. Gonorrhea — Rates by race/ethnicity: United States, 1999–2008
Figure 22. Gonorrhea — Cases by reporting source and sex: United States, 1999–2008
Figure 23. Gonorrhea — Positivity among 15- to 24-year-old women tested in family planning clinics by state: United States and outlying areas, 2008
Figure 24. Location of participating sentinel sites and regional laboratories in the United States, 2008
Figure 25. Gonococcal Isolate Surveillance Project (GISP) — Distribution of MICs to ceftriaxone among GISP isolates, 2004–2008
Figure 26. Distribution of MICs to azithromycin among GISP isolates, 2004–2008
Figure 27. Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates with resistance or intermediate resistance to ciprofloxacin, 1990–2008
Figure 28. Gonococcal Isolate Surveillance Project (GISP) — Penicillin, tetracycline, and ciprofloxacin resistance among GISP isolates, 2008
Figure 29. Gonococcal Isolate Surveillance Project (GISP) — Drugs used to treat gonorrhea in GISP patients, 1988–2008
View all Gonorrhea figures as a color slideshow[PPT 509KB]
Syphilis
Figure 30. Syphilis — Reported cases by stage of infection: United States, 1941–2008
Figure 31. Primary and secondary syphilis — Rates: Total and by sex and male-to-female rate ratios: United States, 1989–2008
Figure 32. Primary and secondary syphilis — Rates by region: United States, 1999–2008
Figure 33. Primary and secondary syphilis — Rates by state: United States and outlying areas, 2008
Figure 34. Primary and secondary syphilis — Rates by county: United States, 2008
Figure 35. Primary and secondary syphilis — Age- and sex-specific rates: United States, 2008
Figure 36. Primary and secondary syphilis — Age-specific rates among women 15 to 44 years of age: United States, 1999–2008
Figure 37. Primary and secondary syphilis — Age-specific rates among men 15 to 44 years of age: United States, 1999–2008
Figure 38. Primary and secondary syphilis — Rates by race/ethnicity: United States, 1999–2008
Figure 39. Primary and secondary syphilis — Reported cases by stage and sexual orientation, 2008
Figure 40. Primary and secondary syphilis — Reported cases by sexual orientation and race/ethnicity, 2008
Figure 41. Primary and secondary syphilis — Reported cases by reporting source and sex: United States, 1999–2008
Figure 42. Primary and secondary syphilis — Percentage of reported cases by sexual orientation and selected reporting sources, 2008
Figure 43. Congenital syphilis (CS)—Reported cases for infants <1 year of age and rates of primary and secondary syphilis among women: United States, 1999–2008
View all Syphilis figures as a color slideshow[PPT 451KB]
Other Sexually Transmitted Diseases
Figure 44. Chancroid — Reported cases: United States, 1981–2008
Figure 45. Human papillomavirus (HPV) — Prevalence of high-risk and low-risk types among females 14 to 59 years of age from a national survey, 2003–2004
Figure 46. Genital warts — Initial visits to physicians’ offices: United States, 1966–2008
Figure 47. Genital herpes — Initial visits to physicians’ offices: United States, 1966–2008
Figure 48. Genital herpes — Herpes simplex virus, type 2, seroprevalence in non-Hispanic whites and non-Hispanic blacks by age group from national surveys, 1976–1980, 1988–1994, 1999–2004
Figure 49. Trichomoniasis and other vaginal infections in women — Initial visits to physicians’ offices: United States, 1966–2008
View all Other STDs figures as a color slideshow[PPT 150KB]
Special Focus Profiles
STDs in Women and Infants
Figure A. Chlamydia — Rates among women by state: United States and outlying areas, 2008
Figure B. Chlamydia — Positivity in 15- to 24-year-old women tested in prenatal clinics by state: United States and outlying areas, 2008
Figure C. Gonorrhea — Rates among women by state: United States and outlying areas, 2008
Figure D. Gonorrhea — Positivity in 15- to 24-year-old women tested in prenatal clinics by state: United States and outlying areas, 2008
Figure E. Primary and secondary syphilis — Rates among women by state: United States and outlying areas, 2008
Figure F. Congenital syphilis — Rates for infants <1 year of age by state: United States and outlying areas, 2008
Figure G. Pelvic inflammatory disease — Hospitalizations of women 15 to 44 years of age: United States, 1997–2006
Figure H. Pelvic inflammatory disease — Initial visits to physicians’ offices by women 15 to 44 years of age: United States, 1999–2008
Figure I. Ectopic pregnancy — Hospitalizations of women 15 to 44 years of age: United States, 1997–2006
View all Women & Infants figures as a color slideshow[PPT 362KB]
STDs in Adolescents and Young Adults
Figure J. Chlamydia — Trends in positivity among 15- to 19-year-old women tested in family planning clinics by DHHS region, 2004–2008
Figure K. Chlamydia — Prevalence among 16- to 24-year-old women entering the National Job Training Program by state of residence: United States and outlying areas, 2008
Figure L. Chlamydia — Prevalence among 16- to 24-year-old men entering the National Job Training Program by state of residence: United States and outlying areas, 2008
Figure M. Gonorrhea — Prevalence among 16- to 24-year-old women entering the National Job Training Program by state of residence: United States and outlying areas, 2008
Figure N. Gonorrhea — Prevalence among 16- to 24-year-old men entering the National Job Training Program by state of residence: United States and outlying areas, 2008
View all Adolescents & Young Adults figures as a color slideshow[PPT 314KB]
STDs in Racial and Ethnic Minorities
Figure O. Chlamydia — Rates by race/ethnicity and sex: United States, 2008
Figure P. Gonorrhea — Rate ratios by race/ethnicity: United States, 1999–2008
Figure Q. Gonorrhea — Rates by race/ethnicity and sex: United States, 2008
Figure R. Gonorrhea — Rate ratios by race/ethnicity and region: United States, 2008
Figure S. Primary and secondary syphilis — Rates by race/ethnicity and sex: United States, 2008
Figure T. Primary and secondary syphilis—Rates among 15- to 19-year-old females by race/ethnicity: United States, 1999–2008
Figure U. Primary and secondary syphilis—Rates among 15- to 19-year-old males by race/ethnicity: United States, 1999–2008
Figure V. Congenital syphilis—Rates among infants <1 year of age by mother’s race/ethnicity: United States, 1999–2008
View all Racial & Ethnic Minorities figures as a color slideshow[PPT 213KB]
STDs in Men Who Have Sex with Men
Figure W. MSM Prevalence Monitoring Project — Number of gonorrhea tests and number of positive tests in men who have sex with men, STD clinics, 1999–2008
Figure X. MSM Prevalence Monitoring Project — Syphilis serologic reactivity among men who have sex with men, STD clinics, 1999–2008
Figure Y. MSM Prevalence Monitoring Project — Clinic-specific median number of HIV tests and positivity among men who have sex with men, STD clinics, 1999–2008
Figure Z. MSM Prevalence Monitoring Project — Test positivity for gonorrhea, chlamydia, and HIV and seroreactivity to syphilis among men who have sex with men, by race/ethnicity, STD clinics, 2008
Figure AA. Gonococcal Isolate Surveillance Project (GISP) — Percent of urethral Neisseria gonorrhoeae isolates obtained from men who have sex with men attending STD clinics, 1989–2008
Figure BB. Gonococcal Isolate Surveillance Project (GISP) — Percent of urethral Neisseria gonorrhoeae isolates obtained from men who have sex with men attending STD clinics by GISP site, 2005–2008
View all Men Who Have Sex with Men figures as a color slideshow[PPT 192KB]
STDs in Persons Entering Corrections Facilities
Figure CC. Chlamydia — Positivity by age and sex, juvenile corrections facilities, 2008
Figure DD. Chlamydia — Positivity by age group and sex, adult corrections facilities, 2008
Figure EE. Gonorrhea — Positivity by age and sex, juvenile corrections facilities, 2008
Figure FF. Gonorrhea — Positivity by age group and sex, adult corrections facilities, 2008
View all Persons Entering Corrections Facilities figures as a color slideshow[PPT 449KB]
ShareCompartir